Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study.

• Main Authors: Yolande F M Ramos, Wouter den Hollander, Judith V M G Bovée, Nils Bomer, Ruud van der Breggen, Nico Lakenberg, J Christiaan Keurentjes, Jelle J Goeman, P Eline Slagboom, Rob G H H Nelissen, Steffan D Bos, Ingrid Meulenbelt
• Format: Article
• Language: English
• Published: Public Library of Science (PLoS) 2014-01-01
• Series: PLoS ONE
• Online Access: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25054223/pdf/?tool=EBI

<h4>Objective</h4>Identify gene expression profiles associated with OA processes in articular cartilage and determine pathways changing during the disease process.<h4>Methods</h4>Genome wide gene expression was determined in paired samples of OA affected and preserved cartilage of the same joint using microarray analysis for 33 patients of the RAAK study. Results were replicated in independent samples by RT-qPCR and immunohistochemistry. Profiles were analyzed with the online analysis tools DAVID and STRING to identify enrichment for specific pathways and protein-protein interactions.<h4>Results</h4>Among the 1717 genes that were significantly differently expressed between OA affected and preserved cartilage we found significant enrichment for genes involved in skeletal development (e.g. TNFRSF11B and FRZB). Also several inflammatory genes such as CD55, PTGES and TNFAIP6, previously identified in within-joint analyses as well as in analyses comparing preserved cartilage from OA affected joints versus healthy cartilage were among the top genes. Of note was the high up-regulation of NGF in OA cartilage. RT-qPCR confirmed differential expression for 18 out of 19 genes with expression changes of 2-fold or higher, and immunohistochemistry of selected genes showed a concordant change in protein expression. Most of these changes associated with OA severity (Mankin score) but were independent of joint-site or sex.<h4>Conclusion</h4>We provide further insights into the ongoing OA pathophysiological processes in cartilage, in particular into differences in macroscopically intact cartilage compared to OA affected cartilage, which seem relatively consistent and independent of sex or joint. We advocate that development of treatment could benefit by focusing on these similarities in gene expression changes and/or pathways.